Genetics and management of retinoblastoma

Journal of Indian Association of Pediatric Surgeons

Volumn 12, Issue 3, 2007, Pages 109-115

  Bakhshi, Sameer ^a   Bakhshi, Radhika ^b  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Childhood; Genetics; Retinal blastoma

Indexed keywords

EID: 35148864071     PISSN: 09719261     EISSN: 09719261     Source Type: Journal    
DOI: 10.4103/0971-9261.34946     Document Type: Article

References (21)

1. Draper GJ, Sanders BM, Brownbill PA, Hawkins MM. Patterns of risk of hereditary retinoblastoma and applications to genetic counseling. Br J Cancer 1992;66:211-9.
2. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol 1963;67:164-72.
3. Grabowski EF, Abramson DH. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am 1987;1:721-35.
4. Hasegawa T, Matsuno Y, Niki T, Hirohashi S, Shimoda T, Takayama J, et al. Second primary rhabdomyosarcomas in patients with bilateral retinoblastoma: A clinicopathologic and immunohistochemical study. Am J Surg Pathol 1998;22:1351-60.
5. Mohney BG, Robertson DM, Schomberg PJ, Hodge DO. Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy. Am J Ophthalmol 1998;126:269-77.
6. Imhof SM, Moll AC, Hofman P, Mourits MP, Schipper J, Tan KE. Second primary tumours in hereditary- and nonhereditary retinoblastoma patients treated with megavoltage external beam irradiation. Doc Ophthalmol 1997;93:337-44.
7. Gallie BL, Budnig A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, et al. Chemotherapy with focal therapy can cure retinoblastoma without radiotherapy. Arch Ophthalmol 1996;114:1321-8.
8. Bechrakis NE, Bornfeld N, Schueler A, Coupland SE, Henze G, Foerster MH. Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol 1998;116:887-93.
9. Gunduz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, et al. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch Ophthalmol 1998;116:1613-7.
10. Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 1997;104:2101-11.
11. Schouten-Van Meeteren AY, Moll AC, Imhof SM, Veerman AJ. Overview: Chemotherapy for retinoblastoma: An expanding area of clinical research, Med Pediatr Oncol 2002;38:428-38.
12. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, et al. Chemoreduction plus focal therapy for retinoblastoma: Factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64.
13. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ. Factors predictive of recurrence of retinal tumors, vitreous seeds and subrelinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002;120:460-4.
14. Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastases in retinoblastoma. Surv Ophthalmol 2002;47:1-16.
15. Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, et al. Post enucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002;120:923-31.
16. Bellaton E, Bertozzi AI, Behar C, Chastagner P, Brisse H, Sainte-Rose C, et al. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol 2003;87:327-9.
17. Shields CL, Honavar S, Shields JA, Demirci H, Meadows AT. Vitrectomy in eyes with unsuspected retinoblastoma. Ophthalmology 2000;107:2250-5.
18. Doz F, Neuenschwander S, Plantaz D, Courbon B, Gentet JC, Bouffet E, et al. Etoposide and carboplatin in extraocular retinoblastoma: A study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 1995;13:902-9.
19. Chantada G, Fandino A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol 2003;40:158-61.
20. Namouni F, Doz F, Tanguy ML, Quintana E, Michon J, Pacquement H, et al. High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: A SFOP and SFGM study. Eur J Cancer 1997;33:2368-75.
21. Rodriguez-Galindo C, Wilson MW, Haik BG, Lipson MJ, Cain A, Merchant TE, et al. Treatment of metastatic retinoblastoma. Ophthalmology 2003;110:1237-40.